ROMANIAN REGISTRY OF RHEUMATIC DISEASES: EFFICACY AND SAFETY OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS

被引：2
|
作者：
Codreanu, C. [1 ]
Mogosan, C. [1 ]
Enache, L. [1 ]
Stanciu, D. [1 ]
Ionescu, R. [2 ]
Opris, D. [2 ]
Rednic, S. [3 ]
Parvu, M. [4 ]
机构：
[1] Clin Ctr Rheumat Dis Dr I Stoia, Rheumatol, Bucharest, Romania
[2] Sfanta Maria Hosp, Rheumatol, Bucharest, Romania
[3] Cty Hosp, Rheumatol, Cluj Napoca, Romania
[4] Colentina Hosp, Rheumatol, Bucharest, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0107
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of a biosimilar rituximab in biologic naïve patients with active rheumatoid arthritis
    Kuttipurath Kandi Roshique
    Vinod Ravindran
    Clinical Rheumatology, 2015, 34 : 1289 - 1292
  • [42] Efficacy and safety of a biosimilar rituximab in biologic na⟨ve patients with active rheumatoid arthritis
    Roshique, Kuttipurath Kandi
    Ravindran, Vinod
    CLINICAL RHEUMATOLOGY, 2015, 34 (07) : 1289 - 1292
  • [43] UNMET THERAPEUTIC NEEDS IN PSORIATIC ARTHRITIS: DATA FROM THE ROMANIAN REGISTRY OF RHEUMATIC DISEASES NEW THERAPIES AND TARGETS
    Codreanu, Catalin O.
    Popescu, Claudiu C.
    Enache, Luminita
    Mogosan, Corina D.
    FARMACIA, 2019, 67 (01) : 10 - 17
  • [44] Unresolved issues in biologic therapy for rheumatoid arthritis
    van Vollenhoven, Ronald F.
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (04) : 205 - 215
  • [45] The Efficacy, Safety and Adherence of Biologic biological Disease-Modifying Anti Rheumatic Drugs, Infliximab, Tocilizumab and Abatacept, in Elderly Patients with Rheumatoid Arthritis
    Wada, Takuma Tsuzuki
    Asanuma, Yu Funakubo
    Matsuda, Mayumi
    Yazawa, Hiroaki
    Nakao, Yoshinobu
    Kozu, Noritsune
    Mimura, Toshihide
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [46] Predictors of Discontinuation of Biologic DMARD Therapy Due to Remission in Patients with Rheumatoid Arthritis in a National Registry
    Gomez-Puerta, Jose A.
    Victoria Hernandez, M.
    Sanchez-Alonso, Fernando
    Yoshida, Kazuki
    Sanmarti, Raimon
    Solomon, Daniel H.
    Gomez-Reino, Juan J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1097 - S1097
  • [47] Unresolved issues in biologic therapy for rheumatoid arthritis
    Ronald F. van Vollenhoven
    Nature Reviews Rheumatology, 2011, 7 : 205 - 215
  • [48] Beyond methotrexate:: biologic therapy in rheumatoid arthritis
    Östör, AJ
    CLINICAL MEDICINE, 2005, 5 (03) : 222 - 226
  • [49] Sequential use of biologic therapy in rheumatoid arthritis
    Buch, Maya H.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 321 - 329
  • [50] BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON A SPANISH REGISTRY: PREDICTORS OF THERAPY DISCONTINUATION DUE TO REMISSION
    Hernandez, M. V.
    Gomez-Puerta, J. A.
    Canete, J. D.
    Gomez-Reino, J. J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 464 - 465
12345